引用次数
引用: 10,354
H-指数: 42
I10-指数 : 69
出版物: 146
Results with $sup 57$Co-labelled bleomycin for tumor scintigraphy
B. Janssen , M. Schmilowski , U. Haubold
Nucl.-Med., Suppl., no. 12, pp. 459-465
1974
Erfahrungen mit hydrophilisierten Silikon-Disk-Intraokularlinsen
C. Mittermayer , H. Harmeyer , B. Janssen , W. Hunold
Fortschritte der Ophthalmologie 88 ( 3) 274 -278
2
1991
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
B. Janssen , D. Hohenadel , P. Brinkkoetter , V. Peters
Diabetes 54 ( 8) 2320 -2327
344
2005
Pulmonary Arterial Hypertension in Patients with Interstitial Pneumonia with Autoimmune Features
B. Janssen , B. Alzghoul , R. Hamburger , T. Lewandowski
B42. ILD EPIDEMIOLOGY I
2020
A CTG Polymorphism in the CNDP1 Gene Determines the Secretion of Serum Carnosinase in Cos-7–Transfected Cells
E. Riedl , H. Koeppel , P. Brinkkoetter , P. Sternik
Diabetes 56 ( 9) 2410 -2413
56
2007
Association Between CNDP1 Genotype and Diabetic Nephropathy Is Sex Specific
A. L. Mooyaart , A. Zutinic , S. J. L. Bakker , D. C. Grootendorst
Diabetes 59 ( 6) 1555 -1559
36
2010
A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans
B. I. Freedman , P. J. Hicks , M. M. Sale , E. D. Pierson
Nephrology Dialysis Transplantation 22 ( 4) 1131 -1135
104
2007
Das Krankheitsbild der myotonen Muskeldystrophie bei Patienten mit großer CTG-Tripletexpansion
M. Spranger , B. Janssen , D. Rating , S. Spranger
Nervenarzt 70 ( 2) 131 -135
8
1999
Network analysis of prostate cancer-derived CWR22, LNCaP and VCAP xenografts for elucidation of the key regulators in castration resistance development
M Cangiano , Z. Granchi , B. Janssen , M. Salji
European Urology Supplements 17 ( 10)
2018
Primary pulmonary hypertension is predominantly a hereditary disease.
E. Grünig , D. Mereles , K. Arnold , A. Benz
Chest 121 ( 3) 81 -82
15
2002
A transcription factor activity profile as a prognostic signature for androgen deprivation therapy resistance predisposition in prostate cancer patients
M. Cangiano , H. Leung , B. Janssen , M. Nykter
European Urology Supplements 18 ( 8)
2019
PF262 COMPREHENSIVE DIAGNOSTICS OF ACUTE MYELOID LEUKEMIA BY WHOLE TRANSCRIPTOME RNA SEQUENCING
M. Griffioen , W. Arindrarto , D.M. Borràs , I.J. Locher
HemaSphere 3 83
2019
Localization of the gene defect in tuberous sclerosis
Halley D , Maat-Kievit A , Lindhout Ed , Janssen B
Tijdschrift Voor Kindergeneeskunde 57 ( 5) 168
1989
Experience with hydrophilic silicone disc intraocular lenses
Mittermayer C , Harmeyer H , Hettlich Hj , Janssen B
Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 88 ( 3) 274
1
1991
Detection of fusion transcripts and their genomic breakpoints from RNA sequencing data
Hoogstrate Y , Dits N , Fijneman Rj , Jenster G
bioRxiv
2021
Locus heterogeneity and the molecular basis of tuberous sclerosis
L.A.J. Janssen
Erasmus University Rotterdam
1995
Genetic heterogeneity in tuberous sclerosis.
L.A.J. Janssen , L.A. Sandkuyl , E.C. Merkens , J.A. Maat-Kievit
Genomics 8 ( 2) 237 -242
50
1990
Linkage investigation of three putative tuberous sclerosis determining loci on chromosomes 9q, 11q, and 12q. The Tuberous Sclerosis Collaborative Group.
J R Sampson , L A Janssen , L A Sandkuijl
Journal of Medical Genetics 29 ( 12) 861 -866
29
1992
Computer simulation of linkage and heterogeneity in tuberous sclerosis: a critical evaluation of the collaborative family data.
L A Janssen , L A Sandkuijl , J R Sampson , D J Halley
Journal of Medical Genetics 29 ( 12) 867 -874
7
1992
INVESTIGATION OF THE CHROMOSOME-9 AND CHROMOSOME-16 TUBEROUS SCLEROSIS LOCI BY HAPLOTYPE ANALYSIS
PB BROOKCARTER , I DANIELS , M NELLIST , D KWIATKOWSKI
CYTOGENETICS AND CELL GENETICS 64 ( 2) 109 -109
1993